Planning system debuts in Philips booth
Other headlinesVarian allies with Calypso to track tumorsNucletron signs oncology outpatient networkFDA clears Chinese 16-slice CT
Planning system debuts in Philips booth
Philips unveils this week a thin-client system that can support up to 16 users of its Pinnacle treatment planning software. The new product, Pinnacle3 SmartEnterprise, debuted yesterday in the Philips booth 26 to 30 at the American Association of Physicists in Medicine meeting in Anaheim, CA. Its centralized database eliminates the need to transfer plan files and streamlines workflow from one user location to another. Advanced treatment planning for image guided radiation therapy supports the handling of 4D image sets. Multiple image sets can be imported with a single mouse click. Expanded DICOM export functionality helps reduce time spent on recomputing data.
Varian allies with Calypso to track tumors
Varian Medical Systems will integrate Calypso Medical Technologies’ real-time localization technology to track tumors. The Calypso technology uses miniature implanted transponders to provide precise, continuous, real-time information about the location of tumors during external beam radiation therapy. The technology complements Varian’s state-of-the-art technology for delivering intensity-modulated radiotherapy, including its RapidArc radiotherapy.
Nucletron signs oncology outpatient network
US Oncology has signed its network of oncology services providers to use Nucletron’s brachytherapy portfolio. Included among the 25 Nucletron systems in the portfolio are the company’s microSelectron 30 Channel Digital high dose rate brachytherapy afterloader and its DICOM-compatible treatment planning system Oncentra Brachy.
FDA clears Chinese 16-slice CT
The NeuViz 16 multi-slice CT scanner from Neusoft Medical Systems has cleared review at the FDA. NeuViz 16 features an advanced detector and dynamic focal spot for high spatial resolution, according to Neusoft. Its DoseRight Modulation and a specially designed pediatric protocol minimizes patient dose. The company commercially launched a PET scanner in May 2009. The company, whose products are widely distributed in China, has subsidiaries in Japan, Europe and the U.S.
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.
